List of bibliographic references indexed by Syndrome respiratoire aigu sévère ()
Number of relevant bibliographic references: 604.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000019 (2020) |
Y J Liu [République populaire de Chine] ; Y L Yang [République populaire de Chine] ; Y. Xu [République populaire de Chine] | [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]. |
| 000143 (2020) |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
| 000188 (2020) |
Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian Guo | Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |
| 000434 (2020) |
Henrik Sjödin [Suède] ; Annelies Wilder-Smith [Allemagne] ; Sarah Osman [Suède] ; Zia Farooq [Suède] ; Joacim Rocklöv [Suède] | Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. |
| 000458 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
| 000602 (2020) |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000713 (2020) |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000878 (2020) |
Paul Webster | Canada and COVID-19: learning from SARS |
| 000883 (2020) |
Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine] | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs |
| 000993 (2020) |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000A73 (2019) |
V M Corman [Allemagne] ; J. Lienau [Allemagne] ; M. Witzenrath [Allemagne] | [Coronaviruses as the cause of respiratory infections]. |
| 000B04 (2019) |
Jos H. Verbeek ; Blair Rajamaki ; Sharea Ijaz ; Christina Tikka ; Jani H. Ruotsalainen ; Michael B. Edmond ; Riitta Sauni ; F Selcen Kilinc Balci | Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. |
| 000B17 (2019) |
Ryan C. Maves ; Christina M. Jamros ; Alfred G. Smith | Intensive Care Unit Preparedness During Pandemics and Other Biological Threats |
| 000B39 (2019) |
Zhiqi Song [République populaire de Chine] ; Yanfeng Xu [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Ling Zhang [République populaire de Chine] ; Pin Yu [République populaire de Chine] ; Yajin Qu [République populaire de Chine] ; Hua Zhu [République populaire de Chine] ; Wenjie Zhao [République populaire de Chine] ; Yunlin Han [République populaire de Chine] ; Chuan Qin [République populaire de Chine] | From SARS to MERS, Thrusting Coronaviruses into the Spotlight |
| 000B44 (2019) |
Varvara A. Mouchtouri ; Eleni P. Christoforidou ; Maria An Der Heiden ; Cinthia Menel Lemos ; Margherita Fanos ; Ute Rexroth ; Ulrike Grote ; Evelien Belfroid ; Corien Swaan ; Christos Hadjichristodoulou | Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact |
| 000C16 (2018) |
Kevin K. C. Hung [Hong Kong] ; Carman K. M. Mark [Hong Kong] ; May P. S. Yeung [Hong Kong] ; Emily Y. Y. Chan [Hong Kong] ; Colin A. Graham [Hong Kong] | The role of the hotel industry in the response to emerging epidemics: a case study of SARS in 2003 and H1N1 swine flu in 2009 in Hong Kong |
| 000C24 (2018) |
Wuqi Qiu [République populaire de Chine] ; Cordia Chu [Australie] ; Ayan Mao [République populaire de Chine] ; Jing Wu [République populaire de Chine] | The Impacts on Health, Society, and Economy of SARS and H7N9 Outbreaks in China: A Case Comparison Study |
| 000C94 (2018) |
Sudhakar Agnihothram [États-Unis] ; Vineet D. Menachery [États-Unis] ; Boyd L. Yount [États-Unis] ; Lisa C. Lindesmith [États-Unis] ; Trevor Scobey [États-Unis] ; Alan Whitmore [États-Unis] ; Alexandra Sch Fer [États-Unis] ; Mark T. Heise [États-Unis] ; Ralph S. Baric [États-Unis] | Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform. |
| 000D40 (2017) |
Anindya Siddharta ; Stephanie Pfaender [Suisse] ; Nathalie Jane Vielle [Suisse] ; Ronald Dijkman [Suisse] ; Martina Friesland ; Britta Becker ; Jaewon Yang [Corée du Sud] ; Michael Engelmann ; Daniel Todt ; Marc P. Windisch [Corée du Sud] ; Florian H. Brill ; Joerg Steinmann ; Jochen Steinmann ; Stephan Becker [Allemagne] ; Marco P. Alves [Suisse] ; Thomas Pietschmann ; Markus Eickmann [Allemagne] ; Volker Thiel [Suisse] ; Eike Steinmann | Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses |
| 000D49 (2017) |
Thiagarajan Venkataraman ; Matthew B. Frieman | The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis |
| 000D95 (2017) |
Wen-Hsiang Chen [États-Unis] ; Shivali M. Chag [États-Unis] ; Mohan V. Poongavanam [États-Unis] ; Amadeo B. Biter [États-Unis] ; Ebe A. Ewere [États-Unis] ; Wanderson Rezende [États-Unis] ; Christopher A. Seid [États-Unis] ; Elissa M. Hudspeth [États-Unis] ; Jeroen Pollet [États-Unis] ; C Patrick Mcatee [États-Unis] ; Ulrich Strych [États-Unis] ; Maria Elena Bottazzi [États-Unis] ; Peter J. Hotez [États-Unis] | Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Syndrome respiratoire aigu sévère ()"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Syndrome respiratoire aigu sévère ()" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Syndrome respiratoire aigu sévère ()
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
